• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶治疗囊性纤维化患者的临床结果及药代动力学

Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.

作者信息

Strandvik B, Malmborg A S, Alfredson H, Ericsson A

出版信息

J Antimicrob Chemother. 1983 Jul;12 Suppl A:283-7. doi: 10.1093/jac/12.suppl_a.283.

DOI:10.1093/jac/12.suppl_a.283
PMID:6352633
Abstract

Ceftazidime (50 mg/kg/8 h) alone or combined with tobramycin (5 mg/kg/8 h) was given to 14 patients with cystic fibrosis. Ten courses were given with ceftazidime alone and 6 courses with a combined therapy. All patients were chronically colonized with Pseudomonas aeruginosa and were hospitalized because of lower respiratory tract infections. Using an agar-well diffusion technique, the concentration of ceftazidime was determined in serum and sputum. The mean (+/- S.E.M.) peak serum concentration of ceftazidime was 142 +/- 16 mg/l during the second to third day of treatment and 114 +/- 18 mg/l on the fifth to sixth day of treatment. In the combined therapy the corresponding values were 104 +/- 20 mg/l and 74 +/- 8 mg/l, respectively. The range of the mean half life was 1.2 to 1.4 h. The maximum concentration of ceftazidime in sputum was usually obtained 1 h after the infusion, ranging from 0.7 to 9.8 mg/l. All patients improved during treatment. Non-mucoid strains of Ps. aeruginosa were eradicated in nearly half of the courses, mucoid strains less often. No side reactions were noted.

摘要

对14例囊性纤维化患者单独给予头孢他啶(50mg/kg/8小时)或联合妥布霉素(5mg/kg/8小时)治疗。单独使用头孢他啶治疗10个疗程,联合治疗6个疗程。所有患者均长期感染铜绿假单胞菌,并因下呼吸道感染住院。采用琼脂孔扩散技术测定血清和痰液中头孢他啶的浓度。治疗第二天至第三天,头孢他啶的平均(±标准误)血清峰值浓度为142±16mg/L,治疗第五天至第六天为114±18mg/L。联合治疗时相应的值分别为104±20mg/L和74±8mg/L。平均半衰期范围为1.2至1.4小时。痰液中头孢他啶的最高浓度通常在输注后1小时达到,范围为0.7至9.8mg/L。所有患者在治疗期间均有改善。近一半疗程中根除了非黏液型铜绿假单胞菌菌株,黏液型菌株较少见。未观察到副作用。

相似文献

1
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.头孢他啶治疗囊性纤维化患者的临床结果及药代动力学
J Antimicrob Chemother. 1983 Jul;12 Suppl A:283-7. doi: 10.1093/jac/12.suppl_a.283.
2
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.头孢他啶单药及联合用药治疗囊性纤维化患者:对洋葱伯克霍尔德菌引起的严重呼吸道感染治疗无效。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:331-6. doi: 10.1093/jac/12.suppl_a.331.
3
Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.头孢他啶治疗囊性纤维化患者慢性铜绿假单胞菌呼吸道感染
J Antimicrob Chemother. 1983 Jul;12 Suppl A:313-23. doi: 10.1093/jac/12.suppl_a.313.
4
Ceftazidime - a significant advance in the treatment of cystic fibrosis.头孢他啶——囊性纤维化治疗的一项重大进展。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:337-40. doi: 10.1093/jac/12.suppl_a.337.
5
Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.用头孢他啶和妥布霉素治疗囊性纤维化患者的慢性铜绿假单胞菌感染。
Scand J Infect Dis. 1983;15(3):271-6. doi: 10.3109/inf.1983.15.issue-3.07.
6
Experience with ceftazidime in cystic fibrosis.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:325-9. doi: 10.1093/jac/12.suppl_a.325.
7
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.每日一次妥布霉素单药治疗囊性纤维化急性肺部加重的疗效:一项初步研究。
Pediatr Pulmonol. 2001 May;31(5):367-76. doi: 10.1002/ppul.1060.
8
Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.头孢他啶在囊性纤维化中的应用:临床、微生物学及免疫学研究
J Antimicrob Chemother. 1983 Jul;12 Suppl A:369-75. doi: 10.1093/jac/12.suppl_a.369.
9
Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:289-95. doi: 10.1093/jac/12.suppl_a.289.
10
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:297-311. doi: 10.1093/jac/12.suppl_a.297.

引用本文的文献

1
Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.抗生素治疗囊性纤维化患者的药代动力学和药效学优化:当前证据、知识空白和未来方向。
Clin Pharmacokinet. 2021 Apr;60(4):409-445. doi: 10.1007/s40262-020-00981-0. Epub 2021 Jan 24.
2
Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers.囊性纤维化患者和健康志愿者中头孢他啶的群体药代动力学比较和药效学折点。
Antimicrob Agents Chemother. 2010 Mar;54(3):1275-82. doi: 10.1128/AAC.00936-09. Epub 2010 Jan 11.
3
Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.
囊性纤维化患者抗菌治疗的药代动力学优化。当前实践及未来方向建议。
Clin Pharmacokinet. 1998 Dec;35(6):437-59. doi: 10.2165/00003088-199835060-00003.
4
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
5
High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.囊性纤维化患者的大剂量抗生素治疗——特别参考成人囊性纤维化患者中β-内酰胺类抗生素和新型氟喹诺酮类药物的药代动力学进行重新评估
Infection. 1987;15(5):385-96. doi: 10.1007/BF01647751.
6
Treatment of respiratory tract infections with cephalosporin antibiotics.用头孢菌素类抗生素治疗呼吸道感染。
Drugs. 1987;34 Suppl 2:180-204. doi: 10.2165/00003495-198700342-00014.
7
Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.囊性纤维化患者的抗生素药代动力学。差异及临床意义。
Clin Pharmacokinet. 1987 Oct;13(4):228-53. doi: 10.2165/00003088-198713040-00002.
8
Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.囊性纤维化中抗生素及其他药物的临床药理学
Drugs. 1988 May;35(5):542-78. doi: 10.2165/00003495-198835050-00004.
9
Prospective study of serum staphylococcal antibodies in cystic fibrosis.囊性纤维化患者血清葡萄球菌抗体的前瞻性研究。
Arch Dis Child. 1987 Sep;62(9):905-11. doi: 10.1136/adc.62.9.905.
10
Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.囊性纤维化患者血清中抗铜绿假单胞菌外毒素蛋白抗体的前瞻性研究。
J Clin Microbiol. 1987 Oct;25(10):1868-74. doi: 10.1128/jcm.25.10.1868-1874.1987.